Abstract: The present disclosure relates to substituted hydroxystilbene compounds and derivatives, specifically 2-substituted hydroxystilbene compounds and derivatives, the synthesis of such compounds and their use in therapy.

Abstract: A compound according to structure USYDS1: wherein the compound is in purified form.

Abstract: A system and method are described herein for estimating power usage of various components of a CPU and controlling voltage regulators based on the estimated power usage. The power estimates may be based on digital power meter readings at each component, on voltage information from a voltage regulator, and on other power information. This power information is transmitted over a mesh interconnect disposed throughout the CPU such that power estimation can be accurately calculated and used to control voltage regulators without being limited by external bus speeds. More of the power management processes and components may be disposed on the CPU and connected to the mesh interconnect. These power management processes include various calibrations, adjustments, and limits so as efficiently manage and use the more rapidly processed power estimations.

Abstract: A compound, composition, or method for treating cancer is disclosed. The compound (that can be used in the composition and/or method) can include or pharmaceutically acceptable salts or solvates thereof. R1a-R1d, R2-R3 (and R4 where applicable), and A---B can be as defined herein.

Abstract: A compound, composition, or method for treating cancer is disclosed. The compound (that can be used in the composition and/or method) can include or pharmaceutically acceptable salts or solvates thereof. R1a-R1d, R2-R3 (and R4 where applicable), and A---B can be as defined herein.

Abstract: The present disclosure is drawn to methods of treating diseases or disorders, and uses of preparing medicaments. The methods of administering and/or preparation of medicaments can include the use of a compound of Formula (I) disclosed herein, or a geometric isomer, stereoisomer, and/or pharmaceutically acceptable salt or solvate thereof.

Abstract: The present disclosure is drawn to methods of treating diseases or disorders, and uses of preparing medicaments. The methods of administering and/or preparation of medicaments can include the use of a compound of Formula (I) disclosed herein, or a geometric isomer, stereoisomer, and/or pharmaceutically acceptable salt or solvate thereof.

Abstract: The present disclosure is drawn to methods of treating diseases or disorders, and uses of preparing medicaments. The methods of administering and/or preparation of medicaments can include the use of a compound of Formula (I) disclosed herein, or a geometric isomer, stereoisomer, and/or pharmaceutically acceptable salt or solvate thereof.

Abstract: The invention relates to terpenes and uses thereof.

Abstract: A compound, composition, or method for treating cancer is disclosed. The compound (that can be used in the composition and/or method) can include or pharmaceutically acceptable salts or solvates thereof. R1a-R1d, R2-R3 (and R4 where applicable), and A---B can be as defined herein.

Abstract: A method for treating cancer can include administering a therapeutically effective amount of a compound of formula (Ia): or pharmaceutically acceptable salts or solvates thereof, wherein R1a, R1b, R1c, R1d, R2, and R3 are as defined, and A----B is selected from CH?CH, CH?CH(CH2)pCH2, or CH2—CH2(CH2)pCH2, and where p is 1 or 2.

Abstract: The invention relates to terpenes and uses thereof.

Abstract: A method for treating cancer can include administering a therapeutically effective amount of a compound of formula (Ia): or pharmaceutically acceptable salts or solvates thereof, wherein R1a, R1b, R1c, R1d, R2, and R3 are as defined, and A----B is selected from CH?CH, CH?CH(CH2)pCH2, or CH2—CH2(CH2)pCH2, and where p is 1 or 2.

Abstract: Prenylated stilbene compounds and the use of such compounds in the treatment of diseases and medical disorders, for example cancer, skin ageing, inflammation, bacterial or fungal infection and immunosuppression.

Abstract: Prenylated stilbene compounds and the use of such compounds in the treatment of diseases and medical disorders, for example cancer, skin ageing, inflammation, bacterial or fungal infection and immunosuppression.

Abstract: A thermoplastic elastomer with increased oil resistance and decreased compression set compared to conventionally cured thermoplastic elastomers may be made from a dynamically vulcanized blend of propylene resin and ethylene/alpha-olefin/non-conjugated diene elastomers via a curing system containing a free radical initiator, a first co-agent including diene-containing polymers with a 1,2-vinyl content greater than 50% by weight, and a second co-agent including multifunctional acrylates containing at least two acrylate groups, multifunctional maleimides containing at least two imide groups, or mixtures of both, where the elastomer gel content in the modified blend is at least 97%.

Abstract: A thermoplastic elastomer with increased oil resistance and decreased compression set compared to conventionally cured thermoplastic elastomers may be made from a dynamically vulcanized blend of propylene resin and ethylene/alpha-olefin/non-conjugated diene elastomers via a curing system containing a free radical initiator, a first co-agent including diene-containing polymers with a 1,2-vinyl content greater than 50% by weight, and a second co-agent including multifunctional acrylates containing at least two acrylate groups, multifunctional maleimides containing at least two imide groups, or mixtures of both, where the elastomer gel content in the modified blend is at least 97%.

Abstract: The invention relates to polymer compositions useful as thermoplastic elastomers for extrusion, calendering, blow molding, thermoforming, and foam processing, and to articles made therefrom. Such improved melt strength thermoplastic elastomers include a blend of propylenic resin (A) and ethylenic elastomer (B), wherein the (A) resin is partially branched and/or the (B) elastomer is partially crosslinked by the addition of multifunctional acrylic monomer (C) containing at least three acrylate groups.

Abstract: The melt strength is increased and the gloss level is reduced in olefinic TPE compositions through the addition of sufficient amounts of free radical generators (A) and co-curative agents (B). The free radical generators (A) include peroxides, organic peroxides, the persulfates, and the diazo compounds, and mixtures thereof. The co-curative agents (B) includes metal salts of alpha, beta-unsaturated carboxylic acids and alpha, beta-unsaturated carboxylic acids where the pending acid group has been neutralized, or mixtures thereof, and the metals for forming the metal salts of co-curative agent (B) include zinc, lithium, calcium, magnesium, sodium or aluminum, or mixtures thereof.

Abstract: The melt strength is increased and the gloss level is reduced in olefinic TPE compositions through the addition of sufficient amounts of free radical generators (A) and co-curative agents (B). The free radical generators (A) include peroxides, organic peroxides, the persulfates, and the diazo compounds, and mixtures thereof. The co-curative agents (B) includes metal salts of alpha, beta-unsaturated carboxylic acids and alpha, beta-unsaturated carboxylic acids where the pending acid group has been neutralized, or mixtures thereof, and the metals for forming the metal salts of co-curative agent (B) include zinc, lithium, calcium, magnesium, sodium or aluminum, or mixtures thereof.